Rare diseases
Investigational molecules
Locations
Back to Romania5 clinical trials in Sangeorgiu De Mures, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents
RomaniaStudy on the Safety of Long-Term Use of Deucrictibant for Treating Hereditary Angioedema Attacks in Patients with C1-Inhibitor Deficiency
RomaniaStudy of Deucrictibant Extended-Release Tablets for Prevention of Hereditary Angioedema Attacks in Adults and Adolescents
RomaniaLong-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II
RomaniaStudy on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on hereditary angioedema (HAE) are evaluating new therapeutic approaches, including the investigation of deucrictibant for both prophylactic treatment and acute attack management.
These studies aim to advance treatment options for patients suffering from this rare genetic condition.
Research initiatives are exploring treatments for seasonal allergic rhinitis and rhinoconjunctivitis, with particular focus on pediatric populations affected by grass pollen allergies.
These trials aim to develop more effective treatment options for seasonal allergies in children.
Clinical investigations are underway examining new treatments for eosinophilic asthma, with studies specifically testing dexpramipexole's effects on pulmonary function.
This research focuses on improving outcomes for patients with specific asthma subtypes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
